The New Standard of Care in Post-Platinum and PD-L1 Inhibitor Setting of Metastatic Urothelial Carcinoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles: